DMK Pharmaceuticals Corp
DMKDelisted Mar 21, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000887247
DMK Pharmaceuticals Corp was delisted on Mar 21, 2024; its insiders filed their last Form 4 on Nov 2, 2023; 29 institutions reported holding it in 13F filings for Q4 2023, worth $350.4K in total; no superinvestor held it.
13F holders, Q1 2022
Institutional positions in DMK Pharmaceuticals Corp as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 46
- −3 vs. Q4 2021
- Shares held
- 12.9M
- −1.26M (−8.9%) vs. Q4 2021
- Total value
- $7.38M
- −$1.20M (−14.0%) vs. Q4 2021
- New holders
- 4
- 7 more added
- Sold out
- 7
- 13 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DMK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 2 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 1 | $0 |
| Q1 2025 | 1 | $0 |
| Q4 2024 | 1 | $0 |
| Q3 2024 | 2 | $0 |
| Q2 2024 | 2 | $0 |
| Q1 2024 | 3 | $4 |
| Q4 2023 | 29 | $350.4K |
| Q3 2023 | 25 | $178.7K |
| Q2 2023 | 22 | $276.4K |
| Q1 2023 | 47 | $3.20M |
| Q4 2022 | 48 | $2.16M |
| Q3 2022 | 43 | $2.55M |
| Q2 2022 | 45 | $6.44M |
| Q1 2022 | 46 | $7.38M |
| Q4 2021 | 49 | $8.58M |
| Q3 2021 | 53 | $14.6M |
| Q2 2021 | 51 | $17.8M |
| Q1 2021 | 53 | $11.8M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding DMK Pharmaceuticals Corp; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Signaturefd, LLC | 863 | $0 | 0.00% | 00.0% | Unchanged |
| Winch Advisory Services, LLC | 73 | $0 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 250 | $0 | 0.00% | +250 | New |
| Wells Fargo & Company | 916 | $1.00K | 0.00% | +3+0.3% | Added |
| Allworth Financial LP | 3,530 | $2.00K | 0.00% | 00.0% | Unchanged |
| Coastal Capital Group, Inc. | 5,100 | $3.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 5,000 | $3.00K | 0.00% | +5,000 | New |
| Cetera Investment Advisers | 10,200 | $6.00K | 0.00% | 00.0% | Unchanged |
| We Are One Seven, LLC | 10,615 | $6.00K | 0.00% | 00.0% | Unchanged |
| Wolff Wiese Magana LLC | 10,740 | $6.00K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 12,615 | $7.00K | 0.00% | −7,021−35.8% | Reduced |
| Squarepoint Ops LLC | 11,729 | $7.00K | 0.00% | −1,927−14.1% | Reduced |
| Advisor Group Holdings, Inc. | 12,691 | $7.00K | 0.00% | 00.0% | Unchanged |
| Oppenheimer & Co Inc | 12,000 | $7.00K | 0.00% | 00.0% | Unchanged |
| Victory Capital Management Inc | 20,426 | $8.00K | 0.00% | −583−2.8% | Reduced |
| Affinity Capital Advisors, LLC | 13,180 | $8.00K | 0.00% | 00.0% | Unchanged |
| Atria Wealth Solutions, Inc. | 15,000 | $9.00K | 0.00% | +15,000 | New |
| Principal Financial Group Inc | 16,872 | $10.0K | 0.00% | −950−5.3% | Reduced |
| Founders Capital Management | 18,000 | $11.0K | 0.01% | 00.0% | Unchanged |
| RVW Wealth, LLC | 19,000 | $11.0K | 0.00% | 00.0% | Unchanged |
| Avantax Advisory Services, Inc. | 22,000 | $13.0K | 0.00% | −32,000−59.3% | Reduced |
| Global Strategic Investment Solutions, LLC | 23,000 | $13.0K | 0.00% | 00.0% | Unchanged |
| Stonebridge Capital Advisors LLC | 22,000 | $13.0K | 0.00% | 00.0% | Unchanged |
| National Asset Management, Inc. | 25,210 | $15.0K | 0.00% | 00.0% | Unchanged |
| Regions Financial Corp | 34,500 | $20.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 41,092 | $24.0K | 0.00% | +6,536+18.9% | Added |
| Lido Advisors, LLC | 46,721 | $26.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 48,048 | $27.0K | 0.00% | −372,803−88.6% | Reduced |
| HighTower Advisors, LLC | 49,350 | $27.0K | 0.00% | +10,000+25.4% | Added |
| Verdence Capital Advisors LLC | 58,382 | $33.0K | 0.00% | −85,000−59.3% | Reduced |
| Charles Schwab Investment Management Inc | 56,257 | $33.0K | 0.00% | 00.0% | Unchanged |
| Cambridge Investment Research Advisors, Inc. | 64,349 | $37.0K | 0.00% | −500−0.8% | Reduced |
| UBS Group AG | 66,653 | $39.0K | 0.00% | −78,691−54.1% | Reduced |
| Capital CS Group, LLC | 70,513 | $40.0K | 0.03% | +70,513 | New |
| JPMorgan Chase & Co | 84,775 | $48.0K | 0.00% | −133,798−61.2% | Reduced |
| Bank of New York Mellon Corp | 84,002 | $48.0K | 0.00% | 00.0% | Unchanged |
| Creative Planning | 85,000 | $49.0K | 0.00% | +63,000+286.4% | Added |
| Edmond de Rothschild Holding S.A. | 100,000 | $57.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 110,228 | $63.0K | 0.00% | −26,935−19.6% | Reduced |
| Tower Research Capital LLC (TRC) | 167,000 | $95.0K | 0.00% | +112,868+208.5% | Added |
| Susquehanna International Group, LLP | 173,979 | $99.0K | 0.00% | −304,382−63.6% | Reduced |
| Northern Trust Corp | 258,851 | $148.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 475,373 | $271.0K | 0.00% | +55,168+13.1% | Added |
| Geode Capital Management, LLC | 1,293,316 | $738.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 2,781,966 | $1.59M | 0.00% | +27,147+1.0% | Added |
| Vanguard Group Inc | 6,480,688 | $3.70M | 0.00% | −38,168−0.6% | Reduced |
| Virtu Financial LLC | 0 | $0 | 0.00% | −224,561−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −138,666−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −75,209−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −41,716−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −22,906−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −21,321−100.0% | Sold out |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −14,643−100.0% | Sold out |